Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Aug;20(5):340-348.
doi: 10.2174/1389202920666190820142043.

Identification of Novel Molecular Network Expression in Acute Myocardial Infarction

Affiliations

Identification of Novel Molecular Network Expression in Acute Myocardial Infarction

Marwa Matboli et al. Curr Genomics. 2019 Aug.

Abstract

Background: In the current study, we aimed to analyze the hypothesis that human myocardial-specific extracellular RNAs expression could be used for acute myocardial injury(AMI) diagnosis.

Methodology: We used bioinformatics' analysis to identify RNAs linked to ubiquitin system and specific to AMI, named, (lncRNA-RP11-175K6.1), (LOC101927740), microRNA-106b-5p (miR-106b-5p) and Anaphase, promoting complex 11 (ANapc11mRNA). We measured the serum expression of the chosen RNAs in 69 individuals with acute coronary syndromes, 31 individuals with angina pectoris without MI and non-cardiac chest pain and 31 healthy control individuals by real-time reverse-transcription PCR.

Results: Our study revealed a significant decrease in both lncRNA-RP11-175K6.1 and ANapc11mRNA expression of in the sera samples of AMI patients compared to that of the two control groups alongside with significant upregulation of miR-106b-5p.

Conclusion: Of note, the investigated serum RNAs decrease the false discovery rate of AMI to 3.2%.

Keywords: Myocardial infarction; diagnosis; extracellular RNAs; lncRNA; miRNA; serum.

PubMed Disclaimer

Figures

Fig. (1)
Fig. (1)
Box plot shows relative expression of the serum RNAs between AMI and control groups. The data is presented as median fold changes (P<0.05).
Fig. (2a)
Fig. (2a)
ROC curve analysis for lncRNA-RP11-175K6 used to calculate the best cut-off point to discriminate between the AMI and healthy groups. AUC [SE]=0.995 [0.024], 95% confidence interval=0.655-0.842, (P<0.01).
Fig. (2b)
Fig. (2b)
ROC curve analysis for RQ-ANPCII mRNA used to calculate the best cut-off point to discriminate between the AMI and control groups. AUC [SE]=0.930 [0.033], 95% confidence interval=0.722-0.811, (P<0.01).
Fig. (2c)
Fig. (2c)
ROC curve analysis for RQ-mIR-106b used to calculate the best cut-off point to discriminate between the AMI and control groups. AUC [SE]=0.995 [0.038], 95% confidence interval=0.845-0.931, (P<0.01).
Fig. (3)
Fig. (3)
A schematic diagram to map the suggested association between the chosen genes. Schematic diagram of the study hypothesis.

References

    1. Shi Q., Yang X. Circulating microRNA and long noncoding RNA as biomarkers of cardiovascular diseases. J. Cell. Physiol. 2016;231(4):751–755. doi: 10.1002/jcp.25174. - DOI - PubMed
    1. Han Q.Y., Wang H.X., Liu X.H., Guo C.X., Hua Q., Yu X.H., Li N., Yang Y.Z., Du J., Xia Y.L., Li H.H. Circulating E3 ligases are novel and sensitive biomarkers for diagnosis of acute myocardial infarction. Clin. Sci. (Lond.) 2015;128(11):751–760. doi: 10.1042/CS20140663. - DOI - PMC - PubMed
    1. Irwin M. Faculty of 1000 evaluation for executive summary: Heart disease and stroke statistics- 2012 update: A report from the American Heart Association. F1000 - Post-publication Peer Review of the Biomedical Literature 2013.
    1. Shams-Vahdati S., Vand-Rajavpour Z., Paknezhad S.P., Piri R., Moghaddasi-Ghezeljeh E., Mirabolfathi S., Naghavi-Behzad M. Cost-effectiveness of cardiac biomarkers as screening test in acute chest pain. J. Cardiovasc. Thorac. Res. 2014;6(1):29–33. - PMC - PubMed
    1. Muhlestein J.B. Biomarkers of Infection and Risk of Coronary Heart Disease. Cardiovascular Biomarkers, 319-344 . 2006.

LinkOut - more resources